Faropenem

DRUG5 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., TASK Applied Science, National University Hospital, Singapore, Dr. Md. Alimur Reza

Conditions

Bacterial PneumoniaCommunity Acquired PneumoniaPneumonia, Community-AcquiredPulmonary TuberculosisTuberculosis

Phase 1

Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers

CompletedNCT02393586

National University Hospital, SingaporeTuberculosis

Start: 2015-02-28End: 2015-10-31Updated: 2017-04-05

Phase 2

Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis

CompletedNCT02349841

TASK Applied SciencePulmonary Tuberculosis

Start: 2014-09-30End: 2014-12-31Updated: 2018-09-13

Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers

CompletedNCT02381470

National University Hospital, SingaporePulmonary Tuberculosis

Start: 2019-02-11End: 2019-10-02Updated: 2020-03-23

Phase 3

A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Community Acquired Pneumonia

Start: 2013-10-31Target: 540Updated: 2013-09-10

Phase 4

Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP)

RecruitingNCT06804096

Dr. Md. Alimur RezaBacterial Pneumonia, Pneumonia, Community-Acquired

Start: 2025-02-20End: 2025-12-01Target: 160Updated: 2025-07-11

Related Papers

Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial.

2017-07-0115 citations